RU2007108214A - METHOD FOR TREATING MEDICINAL POLYNEUROPATHIES CAUSED BY ANTUBERCULOSIS DRUGS - Google Patents

METHOD FOR TREATING MEDICINAL POLYNEUROPATHIES CAUSED BY ANTUBERCULOSIS DRUGS Download PDF

Info

Publication number
RU2007108214A
RU2007108214A RU2007108214/14A RU2007108214A RU2007108214A RU 2007108214 A RU2007108214 A RU 2007108214A RU 2007108214/14 A RU2007108214/14 A RU 2007108214/14A RU 2007108214 A RU2007108214 A RU 2007108214A RU 2007108214 A RU2007108214 A RU 2007108214A
Authority
RU
Russia
Prior art keywords
polyneuropathies
drugs
caused
antuberculosis
treating medicinal
Prior art date
Application number
RU2007108214/14A
Other languages
Russian (ru)
Other versions
RU2353360C2 (en
Inventor
Анатолий Васильевич Лысов (RU)
Анатолий Васильевич Лысов
Анна Владимировна Мордык (RU)
Анна Владимировна Мордык
Анастаси Валерьевна Кондр (RU)
Анастасия Валерьевна Кондря
Борис Владимирович Ковалевский (RU)
Борис Владимирович Ковалевский
Ольга Юрьевна Анфилофьева (RU)
Ольга Юрьевна Анфилофьева
Original Assignee
ГОУ ВПО Омска государственна Медицинска академи (RU)
ГОУ ВПО Омская Государственная Медицинская Академия
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ГОУ ВПО Омска государственна Медицинска академи (RU), ГОУ ВПО Омская Государственная Медицинская Академия filed Critical ГОУ ВПО Омска государственна Медицинска академи (RU)
Priority to RU2007108214/14A priority Critical patent/RU2353360C2/en
Publication of RU2007108214A publication Critical patent/RU2007108214A/en
Application granted granted Critical
Publication of RU2353360C2 publication Critical patent/RU2353360C2/en

Links

Claims (1)

Способ лечения лекарственных полинейропатий, вызванных противотуберкулезными препаратами, характеризующийся тем, что наряду с противотуберкулезной терапией внутримышечно вводят мексидол по 200 мг (4 мл) ежедневно в течение 10 дней, затем переходят на таблетированную форму по 0,125 г три раза в сутки в течение 14 дней.A method for the treatment of polyneuropathies caused by anti-TB drugs, characterized in that, along with anti-TB therapy, 200 mg (4 ml) of Mexidol is administered intramuscularly daily for 10 days, then they switch to a tablet form of 0.125 g three times a day for 14 days.
RU2007108214/14A 2007-03-05 2007-03-05 Antitubeculous-caused medicamentous polyneuropathy approach RU2353360C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2007108214/14A RU2353360C2 (en) 2007-03-05 2007-03-05 Antitubeculous-caused medicamentous polyneuropathy approach

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2007108214/14A RU2353360C2 (en) 2007-03-05 2007-03-05 Antitubeculous-caused medicamentous polyneuropathy approach

Publications (2)

Publication Number Publication Date
RU2007108214A true RU2007108214A (en) 2008-09-10
RU2353360C2 RU2353360C2 (en) 2009-04-27

Family

ID=39866640

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007108214/14A RU2353360C2 (en) 2007-03-05 2007-03-05 Antitubeculous-caused medicamentous polyneuropathy approach

Country Status (1)

Country Link
RU (1) RU2353360C2 (en)

Also Published As

Publication number Publication date
RU2353360C2 (en) 2009-04-27

Similar Documents

Publication Publication Date Title
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
EA200800881A1 (en) DOSAGE FORM OF PYRFENIDONE IN THE FORM OF CAPSULES WITH PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS
AR124500A2 (en) INCREASED BIOAVAILABILITY OF THE DRUG IN NALTREXONE THERAPY
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
EA201100313A1 (en) METHOD OF DELIVERY OF THE PHARMACEUTICAL COMPOSITION TO THE PATIENT NEEDING THIS
NZ714963A (en) Compositions and methods for treating anemia
EA201401028A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY
AR082150A1 (en) N-ETIL-N-Phenyl-1,2-DIHIDRO-4-HYDROXI-5-CHLORINE-1-METHYL-2-OXOQUINOLIN-3-CARBOXAMIDE DEUTERADA, SALTS AND USES OF THE SAME, TREATMENT METHOD, COMPOUND BLEND, COMPOSITION PHARMACEUTICS, PREPARATION PROCESS, ENRICHED COMPOUND WITH DEUTERIO
MX2010005631A (en) Novel cyclic hydrocarbon compounds for the treatment of diseases.
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
UA107578C2 (en) COMBINED DIABETES THERAPY
MY153062A (en) Methods of treating gastrointestinal disorders independent of the intake of food
BR112012000862A8 (en) oral pharmaceutical composition, low dose oral pharmaceutical composition for chronic administration, method of treating or delaying the onset or development of a condition, method of treating pain in an individual in need of this drug, method of treating a condition in an individual who need this medicine
NZ700924A (en) Dosage regimen for a pi-3 kinase inhibitor
EA201270071A1 (en) A METHOD OF TREATING A PATIENT NEEDING ASPIRIN TREATMENT
NO20080244L (en) Dosage control for prasugrel
DK2244703T3 (en) Drug and the preparation and use thereof in the treatment of painful neuropathies
RU2012108144A (en) ANTI-CANCER THERAPY DIRECTED AGAINST CANCER STEM CELLS AND CANCER FORMS RESISTANT TO TREATMENT BY MEDICINES
RU2007108214A (en) METHOD FOR TREATING MEDICINAL POLYNEUROPATHIES CAUSED BY ANTUBERCULOSIS DRUGS
DK2091520T3 (en) ORAL DOSAGE FORM CONTAINING TRISUBSTITUTED GLYCEROL COMPOUNDS
EA200900923A1 (en) APPLICATION OF NEUROPROTECTIVE CONNECTIONS IN THE OBTAINING OF MEDICINES FOR THE TREATMENT OF NEURODEGENERATIVE Diseases
TW200626133A (en) Oral medication for twice-daily administration
RU2012103957A (en) METHOD OF TREATMENT AND PREVENTION OF NASAL OBSTRUCTION IN PATIENTS WITH POLYZAL RHINOSINUSITIS
RU2011101090A (en) METHOD FOR INFLAMMATORY INTESTINAL DISEASES THERAPY
JP2010519274A5 (en)

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090306